ID   ALPK3_HUMAN             Reviewed;        1907 AA.
AC   Q96L96; Q9P2L6;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   12-OCT-2022, entry version 143.
DE   RecName: Full=Alpha-protein kinase 3 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q96QP1};
DE   AltName: Full=Muscle alpha-protein kinase {ECO:0000303|PubMed:10021370};
GN   Name=ALPK3 {ECO:0000312|HGNC:HGNC:17574};
GN   Synonyms=KIAA1330 {ECO:0000303|PubMed:10718198}, MAK
GN   {ECO:0000303|PubMed:10021370};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-1299.
RX   PubMed=10021370; DOI=10.1016/s0960-9822(99)80006-2;
RA   Ryazanov A.G., Pavur K.S., Dorovkov M.V.;
RT   "Alpha-kinases: a new class of protein kinases with a novel catalytic
RT   domain.";
RL   Curr. Biol. 9:R43-R45(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 963-1907, AND VARIANT LEU-1299.
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI. The
RT   complete sequences of 150 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   INVOLVEMENT IN CMH27, AND VARIANT CMH27 1264-TRP--ARG-1907 DEL.
RX   PubMed=27106955; DOI=10.1093/eurheartj/ehw160;
RA   Phelan D.G., Anderson D.J., Howden S.E., Wong R.C., Hickey P.F., Pope K.,
RA   Wilson G.R., Pebay A., Davis A.M., Petrou S., Elefanty A.G., Stanley E.G.,
RA   James P.A., Macciocca I., Bahlo M., Cheung M.M., Amor D.J., Elliott D.A.,
RA   Lockhart P.J.;
RT   "ALPK3-deficient cardiomyocytes generated from patient-derived induced
RT   pluripotent stem cells and mutant human embryonic stem cells display
RT   abnormal calcium handling and establish that ALPK3 deficiency underlies
RT   familial cardiomyopathy.";
RL   Eur. Heart J. 37:2586-2590(2016).
RN   [5]
RP   INVOLVEMENT IN CMH27, AND VARIANTS CMH27 1261-ARG--ARG-1907 DEL AND
RP   1765-TRP--ARG-1907 DEL.
RX   PubMed=26846950; DOI=10.1016/j.jacc.2015.10.093;
RA   Almomani R., Verhagen J.M., Herkert J.C., Brosens E.,
RA   van Spaendonck-Zwarts K.Y., Asimaki A., van der Zwaag P.A.,
RA   Frohn-Mulder I.M., Bertoli-Avella A.M., Boven L.G., van Slegtenhorst M.A.,
RA   van der Smagt J.J., van Ijcken W.F., Timmer B., van Stuijvenberg M.,
RA   Verdijk R.M., Saffitz J.E., du Plessis F.A., Michels M., Hofstra R.M.,
RA   Sinke R.J., van Tintelen J.P., Wessels M.W., Jongbloed J.D.,
RA   van de Laar I.M.;
RT   "Biallelic truncating mutations in ALPK3 cause severe pediatric
RT   cardiomyopathy.";
RL   J. Am. Coll. Cardiol. 67:515-525(2016).
RN   [6]
RP   INVOLVEMENT IN CMH27.
RX   PubMed=28630369; DOI=10.1101/mcs.a001859;
RA   Caglayan A.O., Sezer R.G., Kaymakcalan H., Ulgen E., Yavuz T.,
RA   Baranoski J.F., Bozaykut A., Harmanci A.S., Yalcin Y., Youngblood M.W.,
RA   Yasuno K., Bilguevar K., Gunel M.;
RT   "ALPK3 gene mutation in a patient with congenital cardiomyopathy and
RT   dysmorphic features.";
RL   Cold Spring Harb. Mol. Case Stud. 3:0-0(2017).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-336; ILE-338; SER-414; GLU-433;
RP   GLU-579; ARG-602; ASP-663; MET-761; LEU-836; ASP-929; LEU-1299; GLU-1364;
RP   TRP-1412; ASP-1557 AND PRO-1622.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [8]
RP   INVOLVEMENT IN CMH27.
RX   PubMed=30046096; DOI=10.1038/s10038-018-0492-1;
RA   Jaouadi H., Kraoua L., Chaker L., Atkinson A., Delague V., Levy N.,
RA   Benkhalifa R., Mrad R., Abdelhak S., Zaffran S.;
RT   "Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy
RT   and facio-thoraco-skeletal features.";
RL   J. Hum. Genet. 63:1077-1082(2018).
CC   -!- FUNCTION: Involved in cardiomyocyte differentiation.
CC       {ECO:0000305|PubMed:26846950, ECO:0000305|PubMed:27106955,
CC       ECO:0000305|PubMed:28630369, ECO:0000305|PubMed:30046096}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q96QP1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q96QP1};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q924C5}.
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic 27 (CMH27) [MIM:618052]:
CC       A form of hypertrophic cardiomyopathy, a heart disorder characterized
CC       by ventricular hypertrophy, which is usually asymmetric and often
CC       involves the interventricular septum. The symptoms include dyspnea,
CC       syncope, collapse, palpitations, and chest pain. They can be readily
CC       provoked by exercise. The disorder has inter- and intrafamilial
CC       variability ranging from benign to malignant forms with high risk of
CC       cardiac failure and sudden cardiac death. CMH27 is a severe, early-
CC       onset form with features of hypertrophic and dilated cardiomyopathy.
CC       {ECO:0000269|PubMed:26846950, ECO:0000269|PubMed:27106955,
CC       ECO:0000269|PubMed:28630369, ECO:0000269|PubMed:30046096}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Alpha-type
CC       protein kinase family. ALPK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY044449; AAK95951.1; -; mRNA.
DR   EMBL; AB037751; BAA92568.1; -; mRNA.
DR   EMBL; AC012291; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_065829.3; NM_020778.4.
DR   AlphaFoldDB; Q96L96; -.
DR   SMR; Q96L96; -.
DR   BioGRID; 121597; 6.
DR   IntAct; Q96L96; 8.
DR   STRING; 9606.ENSP00000258888; -.
DR   iPTMnet; Q96L96; -.
DR   PhosphoSitePlus; Q96L96; -.
DR   BioMuta; ALPK3; -.
DR   DMDM; 296434393; -.
DR   EPD; Q96L96; -.
DR   jPOST; Q96L96; -.
DR   MassIVE; Q96L96; -.
DR   PaxDb; Q96L96; -.
DR   PeptideAtlas; Q96L96; -.
DR   PRIDE; Q96L96; -.
DR   ProteomicsDB; 77171; -.
DR   Antibodypedia; 15507; 57 antibodies from 19 providers.
DR   DNASU; 57538; -.
DR   Ensembl; ENST00000258888.6; ENSP00000258888.6; ENSG00000136383.7.
DR   GeneID; 57538; -.
DR   KEGG; hsa:57538; -.
DR   UCSC; uc002ble.3; human.
DR   CTD; 57538; -.
DR   DisGeNET; 57538; -.
DR   GeneCards; ALPK3; -.
DR   HGNC; HGNC:17574; ALPK3.
DR   HPA; ENSG00000136383; Group enriched (heart muscle, skeletal muscle, tongue).
DR   MalaCards; ALPK3; -.
DR   MIM; 617608; gene.
DR   MIM; 618052; phenotype.
DR   neXtProt; NX_Q96L96; -.
DR   PharmGKB; PA134921552; -.
DR   VEuPathDB; HostDB:ENSG00000136383; -.
DR   eggNOG; ENOG502QPP5; Eukaryota.
DR   HOGENOM; CLU_003270_1_0_1; -.
DR   InParanoid; Q96L96; -.
DR   OrthoDB; 32441at2759; -.
DR   PhylomeDB; Q96L96; -.
DR   TreeFam; TF332629; -.
DR   PathwayCommons; Q96L96; -.
DR   SignaLink; Q96L96; -.
DR   BioGRID-ORCS; 57538; 13 hits in 1077 CRISPR screens.
DR   ChiTaRS; ALPK3; human.
DR   GenomeRNAi; 57538; -.
DR   Pharos; Q96L96; Tdark.
DR   PRO; PR:Q96L96; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q96L96; protein.
DR   Bgee; ENSG00000136383; Expressed in gastrocnemius and 131 other tissues.
DR   Genevisible; Q96L96; HS.
DR   GO; GO:0005634; C:nucleus; ISS:HGNC-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0055013; P:cardiac muscle cell development; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; ISS:HGNC-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR004166; MHCK_EF2_kinase.
DR   Pfam; PF02816; Alpha_kinase; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00811; Alpha_kinase; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51158; ALPHA_KINASE; 1.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   Cardiomyopathy; Developmental protein; Disease variant; Disulfide bond;
KW   Immunoglobulin domain; Kinase; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..1907
FT                   /note="Alpha-protein kinase 3"
FT                   /id="PRO_0000260031"
FT   DOMAIN          279..370
FT                   /note="Ig-like 1"
FT   DOMAIN          1476..1564
FT                   /note="Ig-like 2"
FT   DOMAIN          1592..1827
FT                   /note="Alpha-type protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00501"
FT   REGION          65..85
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          110..235
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          413..446
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          510..951
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          994..1047
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1121..1154
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1284..1347
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1375..1428
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1830..1907
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        413..428
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        510..540
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        541..567
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        696..710
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        754..788
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        796..813
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        832..856
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        857..878
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        879..905
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        907..935
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1121..1136
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1846..1900
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         430
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q924C5"
FT   MOD_RES         1424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q924C5"
FT   DISULFID        1498..1548
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VARIANT         336
FT                   /note="R -> H (in dbSNP:rs34407151)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041524"
FT   VARIANT         338
FT                   /note="T -> I (in dbSNP:rs56015306)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041525"
FT   VARIANT         414
FT                   /note="T -> S (in dbSNP:rs3803403)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028989"
FT   VARIANT         433
FT                   /note="Q -> E (in a lung large cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041526"
FT   VARIANT         579
FT                   /note="G -> E (in dbSNP:rs3803405)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028990"
FT   VARIANT         602
FT                   /note="Q -> R (in dbSNP:rs55702300)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041527"
FT   VARIANT         663
FT                   /note="G -> D (in dbSNP:rs34409363)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041528"
FT   VARIANT         761
FT                   /note="T -> M (in dbSNP:rs16974569)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028991"
FT   VARIANT         836
FT                   /note="R -> L (in dbSNP:rs34906636)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041529"
FT   VARIANT         929
FT                   /note="E -> D (in dbSNP:rs56191073)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041530"
FT   VARIANT         1013
FT                   /note="E -> K (in dbSNP:rs35633849)"
FT                   /id="VAR_057743"
FT   VARIANT         1137
FT                   /note="A -> G (in dbSNP:rs34173528)"
FT                   /id="VAR_057744"
FT   VARIANT         1261..1907
FT                   /note="Missing (in CMH27)"
FT                   /evidence="ECO:0000269|PubMed:26846950"
FT                   /id="VAR_079142"
FT   VARIANT         1264..1907
FT                   /note="Missing (in CMH27)"
FT                   /evidence="ECO:0000269|PubMed:27106955"
FT                   /id="VAR_079143"
FT   VARIANT         1299
FT                   /note="P -> L (in dbSNP:rs306197)"
FT                   /evidence="ECO:0000269|PubMed:10021370,
FT                   ECO:0000269|PubMed:10718198, ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028992"
FT   VARIANT         1364
FT                   /note="G -> E (in a metastatic melanoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041531"
FT   VARIANT         1412
FT                   /note="R -> W (in dbSNP:rs55752937)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041532"
FT   VARIANT         1557
FT                   /note="A -> D (in dbSNP:rs34775428)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041533"
FT   VARIANT         1622
FT                   /note="L -> P (in dbSNP:rs187316)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_028993"
FT   VARIANT         1765..1907
FT                   /note="Missing (in CMH27)"
FT                   /evidence="ECO:0000269|PubMed:26846950"
FT                   /id="VAR_079144"
FT   VARIANT         1873
FT                   /note="A -> V (in dbSNP:rs36002219)"
FT                   /id="VAR_057745"
FT   CONFLICT        210
FT                   /note="S -> T (in Ref. 1; AAK95951)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1907 AA;  201272 MW;  3896A1EC187BF5C7 CRC64;
     MEVAWLVYVL GQQPLARQGE GQSRLVPGRG LVLWLPGLPR SSPSWPAVDL APLAPARPRG
     PLICHTGHEQ AGREPGPGSS TKGPVLHDQD TRCAFLPRPP GPLQTRRYCR HQGRQGSGLG
     AGPGAGTWAP APPGVSKPRC PGRARPGEGQ QQVTTARPPA INRGARQPRA GAAAAGRGPG
     AGAWRTGEAA ASAGPAVGEG GAMGSRRAPS RGWGAGGRSG AGGDGEDDGP VWIPSPASRS
     YLLSVRPETS LSSNRLSHPS SGRSTFCSII AQLTEETQPL FETTLKSRSV SEDSDVRFTC
     IVTGYPEPEV TWYKDDTELD RYCGLPKYEI THQGNRHTLQ LYRCREEDAA IYQASAQNSK
     GIVSCSGVLE VGTMTEYKIH QRWFAKLKRK AAAKLREIEQ SWKHEKAVPG EVDTLRKLSP
     DRFQRKRRLS GAQAPGPSVP TREPEGGTLA AWQEGETETA QHSGLGLINS FASGEVTTNG
     EAAPENGEDG EHGLLTYICD AMELGPQRAL KEESGAKKKK KDEESKQGLR KPELEKAAQS
     RRSSENCIPS SDEPDSCGTQ GPVGVEQVQT QPRGRAARGP GSSGTDSTRK PASAVGTPDK
     AQKAPGPGPG QEVYFSLKDM YLENTQAVRP LGEEGPQTLS VRAPGESPKG KAPLRARSEG
     VPGAPGQPTH SLTPQPTRPF NRKRFAPPKP KGEATTDSKP ISSLSQAPEC GAQSLGKAPP
     QASVQVPTPP ARRRHGTRDS TLQGQAGHRT PGEVLECQTT TAPTMSASSS SDVASIGVST
     SGSQGIIEPM DMETQEDGRT SANQRTGSKK NVQADGKIQV DGRTRGDGTQ TAQRTRADRK
     TQVDAGTQES KRPQSDRSAQ KGMMTQGRAE TQLETTQAGE KIQEDRKAQA DKGTQEDRRM
     QGEKGMQGEK GTQSEGSAPT AMEGQSEQEV ATSLGPPSRT PKLPPTAGPR APLNIECFVQ
     TPEGSCFPKK PGCLPRSEEA VVTASRNHEQ TVLGPLSGNL MLPAQPPHEG SVEQVGGERC
     RGPQSSGPVE AKQEDSPFQC PKEERPGGVP CMDQGGCPLA GLSQEVPTMP SLPGTGLTAS
     PKAGPCSTPT SQHGSTATFL PSEDQVLMSS APTLHLGLGT PTQSHPPETM ATSSEGACAQ
     VPDVEGRTPG PRSCDPGLID SLKNYLLLLL KLSSTETSGA GGESQVGAAT GGLVPSATLT
     PTVEVAGLSP RTSRRILERV ENNHLVQSAQ TLLLSPCTSR RLTGLLDREV QAGRQALAAA
     RGSWGPGPSS LTVPAIVVDE EDPGLASEGA SEGEGEVSPE GPGLLGASQE SSMAGRLGEA
     GGQAAPGQGP SAESIAQEPS QEEKFPGEAL TGLPAATPEE LALGARRKRF LPKVRAAGDG
     EATTPEERES PTVSPRGPRK SLVPGSPGTP GRERRSPTQG RKASMLEVPR AEEELAAGDL
     GPSPKAGGLD TEVALDEGKQ ETLAKPRKAK DLLKAPQVIR KIRVEQFPDA SGSLKLWCQF
     FNILSDSVLT WAKDQRPVGE VGRSAGDEGP AALAIVQASP VDCGVYRCTI HNEHGSASTD
     FCLSPEVLSG FISREEGEVG EEIEMTPMVF AKGLADSGCW GDKLFGRLVS EELRGGGYGC
     GLRKASQAKV IYGLEPIFES GRTCIIKVSS LLVFGPSSET SLVGRNYDVT IQGCKIQNMS
     REYCKIFAAE ARAAPGFGEV PEIIPLYLIY RPANNIPYAT LEEDLGKPLE SYCSREWGCA
     EAPTASGSSE AMQKCQTFQH WLYQWTNGSF LVTDLAGVDW KMTDVQIATK LRGYQGLKES
     CFPALLDRFA SSHQCNAYCE LLGLTPLKGP EAAHPQAKAK GSKSPSAGRK GSQLSPQPQK
     KGLPSPQGTR KSAPSSKATP QASEPVTTQL LGQPPTQEEG SKAQGMR
//
